A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck†
Identifieur interne : 000273 ( Ncbi/Curation ); précédent : 000272; suivant : 000274A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck†
Auteurs : T. Y. Seiwert [États-Unis] ; J. Fayette ; D. Cupissol [France] ; J. M. Del Campo [Espagne] ; P. M. Clement [Belgique] ; R. Hitt [Espagne] ; M. Degardin [France] ; W. Zhang [République populaire de Chine] ; A. Blackman [États-Unis] ; E. Ehrnrooth [Danemark] ; E. E. W. Cohen [États-Unis]Source :
- Annals of Oncology [ 0923-7534 ] ; 2014.
Abstract
Afatinib, an oral irreversible ErbB family blocker, showed comparable activity to cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma in this phase II trial. Further, sequential EGFR/ErbB treatment provided sustained clinical benefit in some patients, suggesting a lack of cross-resistance.
Url:
DOI: 10.1093/annonc/mdu216
PubMed: 24928832
PubMed Central: 4143093
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000302
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :000302
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000072
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000273
Links to Exploration step
PMC:4143093Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck<sup><xref ref-type="author-notes" rid="mdu216_AN1">†</xref>
</sup>
</title>
<author><name sortKey="Seiwert, T Y" sort="Seiwert, T Y" uniqKey="Seiwert T" first="T. Y." last="Seiwert">T. Y. Seiwert</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af1"><addr-line>Department of Medicine</addr-line>
,<institution>University of Chicago Medical Centre</institution>
,<addr-line>Chicago</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fayette, J" sort="Fayette, J" uniqKey="Fayette J" first="J." last="Fayette">J. Fayette</name>
<affiliation><nlm:aff id="mdu216_af2"><addr-line>Department of Medicine</addr-line>
,<institution>Université de Lyon</institution>
,<addr-line>Lyon</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cupissol, D" sort="Cupissol, D" uniqKey="Cupissol D" first="D." last="Cupissol">D. Cupissol</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af3"><institution>Institut du Cancer de Montpellier Val d'Aurelle</institution>
,<addr-line>Montpellier</addr-line>
,<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Del Campo, J M" sort="Del Campo, J M" uniqKey="Del Campo J" first="J. M." last="Del Campo">J. M. Del Campo</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af4"><addr-line>Department of Medical Oncology</addr-line>
,<institution>Hospital Universitario Vall d'Hebron</institution>
,<addr-line>Barcelona</addr-line>
,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clement, P M" sort="Clement, P M" uniqKey="Clement P" first="P. M." last="Clement">P. M. Clement</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af5"><addr-line>Division of Oncology</addr-line>
,<institution>KU Leuven</institution>
,<addr-line>Leuven</addr-line>
,<country>Belgium</country>
</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hitt, R" sort="Hitt, R" uniqKey="Hitt R" first="R." last="Hitt">R. Hitt</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af6"><addr-line>Centro Integral Oncológico Clara Campal (CIOCC), Madrid</addr-line>
,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Degardin, M" sort="Degardin, M" uniqKey="Degardin M" first="M." last="Degardin">M. Degardin</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af7"><institution>Centre Oscar Lambret</institution>
,<addr-line>Lille</addr-line>
,<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af8"><institution>Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd</institution>
,<addr-line>Shanghai</addr-line>
,<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Blackman, A" sort="Blackman, A" uniqKey="Blackman A" first="A." last="Blackman">A. Blackman</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af9"><institution>Boehringer Ingelheim Pharmaceuticals, Inc.</institution>
,<addr-line>Ridgefield</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ehrnrooth, E" sort="Ehrnrooth, E" uniqKey="Ehrnrooth E" first="E." last="Ehrnrooth">E. Ehrnrooth</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af10"><institution>Boehringer Ingelheim</institution>
<addr-line>Danmark A/S</addr-line>
,<country>Copenhagen, Denmark</country>
</nlm:aff>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cohen, E E W" sort="Cohen, E E W" uniqKey="Cohen E" first="E. E. W." last="Cohen">E. E. W. Cohen</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af11"><addr-line>Department of Medicine</addr-line>
,<institution>University of California San Diego Moores Cancer Center</institution>
,<addr-line>La Jolla</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">24928832</idno>
<idno type="pmc">4143093</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143093</idno>
<idno type="RBID">PMC:4143093</idno>
<idno type="doi">10.1093/annonc/mdu216</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000302</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000302</idno>
<idno type="wicri:Area/Pmc/Curation">000302</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000302</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000072</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000072</idno>
<idno type="wicri:Area/Ncbi/Merge">000273</idno>
<idno type="wicri:Area/Ncbi/Curation">000273</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck<sup><xref ref-type="author-notes" rid="mdu216_AN1">†</xref>
</sup>
</title>
<author><name sortKey="Seiwert, T Y" sort="Seiwert, T Y" uniqKey="Seiwert T" first="T. Y." last="Seiwert">T. Y. Seiwert</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af1"><addr-line>Department of Medicine</addr-line>
,<institution>University of Chicago Medical Centre</institution>
,<addr-line>Chicago</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Fayette, J" sort="Fayette, J" uniqKey="Fayette J" first="J." last="Fayette">J. Fayette</name>
<affiliation><nlm:aff id="mdu216_af2"><addr-line>Department of Medicine</addr-line>
,<institution>Université de Lyon</institution>
,<addr-line>Lyon</addr-line>
</nlm:aff>
</affiliation>
</author>
<author><name sortKey="Cupissol, D" sort="Cupissol, D" uniqKey="Cupissol D" first="D." last="Cupissol">D. Cupissol</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af3"><institution>Institut du Cancer de Montpellier Val d'Aurelle</institution>
,<addr-line>Montpellier</addr-line>
,<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Del Campo, J M" sort="Del Campo, J M" uniqKey="Del Campo J" first="J. M." last="Del Campo">J. M. Del Campo</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af4"><addr-line>Department of Medical Oncology</addr-line>
,<institution>Hospital Universitario Vall d'Hebron</institution>
,<addr-line>Barcelona</addr-line>
,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Clement, P M" sort="Clement, P M" uniqKey="Clement P" first="P. M." last="Clement">P. M. Clement</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af5"><addr-line>Division of Oncology</addr-line>
,<institution>KU Leuven</institution>
,<addr-line>Leuven</addr-line>
,<country>Belgium</country>
</nlm:aff>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hitt, R" sort="Hitt, R" uniqKey="Hitt R" first="R." last="Hitt">R. Hitt</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af6"><addr-line>Centro Integral Oncológico Clara Campal (CIOCC), Madrid</addr-line>
,<country>Spain</country>
</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Degardin, M" sort="Degardin, M" uniqKey="Degardin M" first="M." last="Degardin">M. Degardin</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af7"><institution>Centre Oscar Lambret</institution>
,<addr-line>Lille</addr-line>
,<country>France</country>
</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Zhang, W" sort="Zhang, W" uniqKey="Zhang W" first="W." last="Zhang">W. Zhang</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af8"><institution>Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd</institution>
,<addr-line>Shanghai</addr-line>
,<country>China</country>
</nlm:aff>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Blackman, A" sort="Blackman, A" uniqKey="Blackman A" first="A." last="Blackman">A. Blackman</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af9"><institution>Boehringer Ingelheim Pharmaceuticals, Inc.</institution>
,<addr-line>Ridgefield</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ehrnrooth, E" sort="Ehrnrooth, E" uniqKey="Ehrnrooth E" first="E." last="Ehrnrooth">E. Ehrnrooth</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af10"><institution>Boehringer Ingelheim</institution>
<addr-line>Danmark A/S</addr-line>
,<country>Copenhagen, Denmark</country>
</nlm:aff>
<country xml:lang="fr">Danemark</country>
<wicri:regionArea></wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Cohen, E E W" sort="Cohen, E E W" uniqKey="Cohen E" first="E. E. W." last="Cohen">E. E. W. Cohen</name>
<affiliation wicri:level="1"><nlm:aff id="mdu216_af11"><addr-line>Department of Medicine</addr-line>
,<institution>University of California San Diego Moores Cancer Center</institution>
,<addr-line>La Jolla</addr-line>
,<country>USA</country>
</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea># see nlm:aff country strict</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Annals of Oncology</title>
<idno type="ISSN">0923-7534</idno>
<idno type="eISSN">1569-8041</idno>
<imprint><date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>Afatinib, an oral irreversible ErbB family blocker, showed comparable activity to cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma in this phase II trial. Further, sequential EGFR/ErbB treatment provided sustained clinical benefit in some patients, suggesting a lack of cross-resistance.</p>
</div>
</front>
<back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Ferlay, J" uniqKey="Ferlay J">J Ferlay</name>
</author>
<author><name sortKey="Shin, Hr" uniqKey="Shin H">HR Shin</name>
</author>
<author><name sortKey="Bray, F" uniqKey="Bray F">F Bray</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Seiwert, Ty" uniqKey="Seiwert T">TY Seiwert</name>
</author>
<author><name sortKey="Salama, Jk" uniqKey="Salama J">JK Salama</name>
</author>
<author><name sortKey="Vokes, Ee" uniqKey="Vokes E">EE Vokes</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Gold, Ka" uniqKey="Gold K">KA Gold</name>
</author>
<author><name sortKey="Lee, Hy" uniqKey="Lee H">HY Lee</name>
</author>
<author><name sortKey="Kim, Es" uniqKey="Kim E">ES Kim</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hayes, Dn" uniqKey="Hayes D">DN Hayes</name>
</author>
<author><name sortKey="Grandis, J" uniqKey="Grandis J">J Grandis</name>
</author>
<author><name sortKey="El Naggar, Ak" uniqKey="El Naggar A">AK El-Naggar</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Vermorken, Jb" uniqKey="Vermorken J">JB Vermorken</name>
</author>
<author><name sortKey="Trigo, J" uniqKey="Trigo J">J Trigo</name>
</author>
<author><name sortKey="Hitt, R" uniqKey="Hitt R">R Hitt</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Burtness, B" uniqKey="Burtness B">B Burtness</name>
</author>
<author><name sortKey="Goldwasser, Ma" uniqKey="Goldwasser M">MA Goldwasser</name>
</author>
<author><name sortKey="Flood, W" uniqKey="Flood W">W Flood</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Vermorken, Jb" uniqKey="Vermorken J">JB Vermorken</name>
</author>
<author><name sortKey="Mesia, R" uniqKey="Mesia R">R Mesia</name>
</author>
<author><name sortKey="Rivera, F" uniqKey="Rivera F">F Rivera</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sok, Jc" uniqKey="Sok J">JC Sok</name>
</author>
<author><name sortKey="Coppelli, Fm" uniqKey="Coppelli F">FM Coppelli</name>
</author>
<author><name sortKey="Thomas, Sm" uniqKey="Thomas S">SM Thomas</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Li, D" uniqKey="Li D">D Li</name>
</author>
<author><name sortKey="Ambrogio, L" uniqKey="Ambrogio L">L Ambrogio</name>
</author>
<author><name sortKey="Shimamura, T" uniqKey="Shimamura T">T Shimamura</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Solca, F" uniqKey="Solca F">F Solca</name>
</author>
<author><name sortKey="Dahl, G" uniqKey="Dahl G">G Dahl</name>
</author>
<author><name sortKey="Zoephel, A" uniqKey="Zoephel A">A Zoephel</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Sequist, Lv" uniqKey="Sequist L">LV Sequist</name>
</author>
<author><name sortKey="Yang, Jc" uniqKey="Yang J">JC Yang</name>
</author>
<author><name sortKey="Yamamoto, N" uniqKey="Yamamoto N">N Yamamoto</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Yang, Jc" uniqKey="Yang J">JC Yang</name>
</author>
<author><name sortKey="Hirsh, V" uniqKey="Hirsh V">V Hirsh</name>
</author>
<author><name sortKey="Schuler, M" uniqKey="Schuler M">M Schuler</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Cohen, Ee" uniqKey="Cohen E">EE Cohen</name>
</author>
<author><name sortKey="Rosen, F" uniqKey="Rosen F">F Rosen</name>
</author>
<author><name sortKey="Stadler, Wm" uniqKey="Stadler W">WM Stadler</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Perez, Ca" uniqKey="Perez C">CA Perez</name>
</author>
<author><name sortKey="Song, H" uniqKey="Song H">H Song</name>
</author>
<author><name sortKey="Raez, Le" uniqKey="Raez L">LE Raez</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Soulieres, D" uniqKey="Soulieres D">D Soulieres</name>
</author>
<author><name sortKey="Senzer, Nn" uniqKey="Senzer N">NN Senzer</name>
</author>
<author><name sortKey="Vokes, Ee" uniqKey="Vokes E">EE Vokes</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Stewart, Js" uniqKey="Stewart J">JS Stewart</name>
</author>
<author><name sortKey="Cohen, Ee" uniqKey="Cohen E">EE Cohen</name>
</author>
<author><name sortKey="Licitra, L" uniqKey="Licitra L">L Licitra</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Aaronson, Nk" uniqKey="Aaronson N">NK Aaronson</name>
</author>
<author><name sortKey="Ahmedzai, S" uniqKey="Ahmedzai S">S Ahmedzai</name>
</author>
<author><name sortKey="Bergman, B" uniqKey="Bergman B">B Bergman</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Bjordal, K" uniqKey="Bjordal K">K Bjordal</name>
</author>
<author><name sortKey="Hammerlid, E" uniqKey="Hammerlid E">E Hammerlid</name>
</author>
<author><name sortKey="Ahlner Elmqvist, M" uniqKey="Ahlner Elmqvist M">M Ahlner-Elmqvist</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Jeuken, J" uniqKey="Jeuken J">J Jeuken</name>
</author>
<author><name sortKey="Sijben, A" uniqKey="Sijben A">A Sijben</name>
</author>
<author><name sortKey="Alenda, C" uniqKey="Alenda C">C Alenda</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Lavin, Pt" uniqKey="Lavin P">PT Lavin</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Karrison, Tg" uniqKey="Karrison T">TG Karrison</name>
</author>
<author><name sortKey="Maitland, Ml" uniqKey="Maitland M">ML Maitland</name>
</author>
<author><name sortKey="Stadler, Wm" uniqKey="Stadler W">WM Stadler</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Stransky, N" uniqKey="Stransky N">N Stransky</name>
</author>
<author><name sortKey="Egloff, Am" uniqKey="Egloff A">AM Egloff</name>
</author>
<author><name sortKey="Tward, Ad" uniqKey="Tward A">AD Tward</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Hirsh, V" uniqKey="Hirsh V">V Hirsh</name>
</author>
</analytic>
</biblStruct>
<biblStruct><analytic><author><name sortKey="Yang, Jc" uniqKey="Yang J">JC Yang</name>
</author>
<author><name sortKey="Reguart, N" uniqKey="Reguart N">N Reguart</name>
</author>
<author><name sortKey="Barinoff, J" uniqKey="Barinoff J">J Barinoff</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000273 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000273 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Psychologie |area= TherFamFrancoV1 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:4143093 |texte= A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck† }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:24928832" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a TherFamFrancoV1
![]() | This area was generated with Dilib version V0.6.29. | ![]() |